Anteilseigner
Bain Capital Life Sciences LP (10,57 %) Invus Public Equities Advisors LLC (9,63 %) Adage Capital Management LP (7,97 %) Samsara Biocapital LLC (6,87 %) Avidity Partners Management LP (6,44 %) Blue Owl Healthcare Opportunities Advisors LLC (5,74 %) Point72 Asset Management LP (5,66 %) CHI Advisors LLC (5,00 %) Flagship Pioneering (4,98 %) Deep Track Capital LP (3,19 %) The Vanguard Group, Inc. (2,93 %) Opaleye Management, Inc. (1,38 %) Omega Fund Management LLC (0,97 %) Ally Bridge Group HK Ltd (0,96 %) BlackRock Fund Advisors (0,93 %) Goldman Sachs & Co. LLC (Private Banking) (0,92 %) DAFNA Capital Management LLC (0,83 %) Medical Strategy GmbH (0,70 %) Geode Capital Management LLC (0,62 %) UBS O'Connor LLC (0,50 %)
Kontakt
Syros Pharmaceuticals Inc.